Yingmiao Liu Selected Research

Yingmiao Liu Research Topics

Disease

18	Neoplasms (Cancer) 01/2022 - 01/2006
10	Colorectal Neoplasms (Colorectal Cancer) 03/2022 - 01/2010
5	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2009
3	Renal Cell Carcinoma (Grawitz Tumor) 01/2022 - 01/2019
2	Inflammation (Inflammations) 01/2022 - 01/2020
2	Hypertension (High Blood Pressure) 01/2022 - 01/2022
2	Hypoxia (Hypoxemia) 01/2022 - 01/2008
2	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 01/2020
2	Hemorrhage 01/2021 - 10/2020
2	Thrombosis (Thrombus) 01/2021 - 02/2020
2	Breast Neoplasms (Breast Cancer) 01/2021 - 01/2009
2	Kidney Neoplasms (Kidney Cancer) 01/2020 - 01/2019
2	Carcinogenesis 01/2020 - 01/2009
2	Colonic Neoplasms (Colon Cancer) 03/2013 - 01/2010
2	Adenocarcinoma of Lung 08/2007 - 01/2006
1	Periodontitis 01/2022
1	Rectal Neoplasms (Rectal Cancer) 01/2022
1	Adenocarcinoma 01/2022
1	Thromboembolism 01/2021
1	Familial cerebral cavernous malformation 01/2021
1	Arteriovenous Malformations (Arteriovenous Malformation) 01/2021
1	Hereditary Hemorrhagic Telangiectasia 01/2021
1	Triple Negative Breast Neoplasms 01/2021
1	Vascular Malformations 01/2021
1	Colitis 02/2020
1	Ovarian Epithelial Carcinoma 01/2020
1	Biliary Tract Neoplasms (Biliary Tract Cancer) 01/2020
1	Pancreatic Neoplasms (Pancreatic Cancer) 01/2020
1	Disease Progression 01/2020
1	Squamous Cell Carcinoma of Head and Neck 07/2019
1	Multiple Myeloma 06/2018
1	Polyps 12/2017
1	Medulloblastoma 09/2017
1	Craniocerebral Trauma (Head Injury) 02/2017
1	Choroidal Neovascularization 10/2014

Drug/Important Bio-Agent (IBA)

15	Biomarkers (Surrogate Marker)IBA 03/2022 - 04/2013
8	Bevacizumab (Avastin)FDA Link 01/2022 - 04/2013
7	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2022 - 08/2007
7	EndoglinIBA 01/2021 - 06/2014
6	Proteins (Proteins, Gene)FDA Link 01/2022 - 02/2009
6	carotuximabIBA 01/2021 - 06/2014
5	Nucleotide AptamersIBA 01/2010 - 08/2007
4	CytokinesIBA 01/2022 - 07/2019
4	PhosphatidylserinesIBA 01/2022 - 06/2018
4	regorafenibIBA 01/2022 - 10/2019
3	Pharmaceutical PreparationsIBA 01/2022 - 01/2019
3	Monoclonal AntibodiesIBA 01/2021 - 01/2019
3	NF-kappa B (NF-kB)IBA 01/2008 - 01/2006
2	Capecitabine (Xeloda)FDA Link 01/2022 - 04/2013
2	Angiopoietin-2IBA 01/2022 - 01/2022
2	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 01/2022 - 01/2022
2	Blood Proteins (Serum Proteins)IBA 01/2022 - 01/2022
2	Fibrinogen (Factor I)FDA Link 01/2021 - 10/2020
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 01/2008
2	Axitinib (AG 013736)IBA 01/2021 - 01/2019
2	Glycoproteins (Glycoprotein)IBA 10/2014 - 02/2009
1	cabozantinibIBA 03/2022
1	Panitumumab (Vectibix)FDA Link 03/2022
1	prothrombinase complexIBA 01/2022
1	lenvatinibIBA 01/2022
1	Cetuximab (Erbitux)FDA Link 01/2022
1	inhibin AIBA 01/2022
1	Activins (Activin)IBA 01/2022
1	Inhibins (Inhibin)IBA 01/2022
1	LigandsIBA 01/2022
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2021
1	((3- (bis(2- chloroethyl)amino)- 4- methylphenyl)hydroxymethane)bisphosphonic acidIBA 01/2021
1	Transforming Growth Factors (Transforming Growth Factor)IBA 12/2020
1	Neutralizing AntibodiesIBA 12/2020
1	Tyrosine Kinase InhibitorsIBA 10/2020
1	adhesion receptorIBA 10/2020
1	Deoxyribonucleases (DNase)FDA Link 02/2020
1	SodiumIBA 02/2020
1	Drinking WaterIBA 02/2020
1	Dextrans (Dextran)FDA Link 02/2020
1	durvalumabIBA 01/2020
1	olaparibIBA 01/2020
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	AntibodiesIBA 01/2020
1	PlatinumIBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	Carboplatin (JM8)FDA LinkGeneric 01/2020
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2020
1	Activin Receptors (Activin Receptor)IBA 10/2019
1	ascrinvacumabIBA 10/2019
1	Dexamethasone (Maxidex)FDA LinkGeneric 06/2018
1	Immunomodulating AgentsIBA 06/2018
1	Adenosine Triphosphate (ATP)IBA 12/2017
1	EnzymesIBA 12/2017
1	Cytidine Diphosphate Choline (Citicoline)IBA 02/2017
1	Everolimus FDA Link 04/2015
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 04/2013
1	IntegrinsIBA 03/2013

Therapy/Procedure

8	Therapeutics 01/2022 - 02/2009
5	Drug Therapy (Chemotherapy) 01/2022 - 01/2008
2	Neoadjuvant Therapy 01/2022 - 01/2021
1	Radiotherapy 01/2022
1	Adjuvant Chemotherapy 01/2022
1	Intravenous Injections 01/2021